Table 1.
Patient characteristics prior to 90Y-microsphere treatment
| Characteristic | Statistic | |
|---|---|---|
| Age (years) | ||
| Median (range) | 57.5 (18–78) | |
| >65 years, n (%) | 9 (41%) | |
| Gender, n (%) | ||
| Male | 20 (91%) | |
| Female | 2 (9%) | |
| Extrahepatic Disease, n (%) | ||
| No | 19 (86%) | |
| Yes | 3 (14%) | |
| Ascites, n (%) | ||
| Grade 0 | 15 (68%) | |
| Grade 1–2 | 5 (23%) | |
| Grade 3–4 | 2 (9%) | |
| Serum Total Bilirubin (mg/dL) | ||
| Median (range) | 0.85 (0.1–7.3) | |
| >1.2 mg/dL, n (%) | 9 (41%) | |
| Tumor Distribution, n (%) | ||
| Unilobar | 10 (45%) | |
| Bilobar | 12 (55%) | |
| Tumor Morphology, n (%) | ||
| Uninodular, <50% Replacement | 3 (14%) | |
| Multinodular, <50% Replacement | 15 (68%) | |
| Massive, ≥50% Replacement | 4 (18%) | |
| Child-Pugh Score, n (%) | ||
| A | 12 (55%) | |
| B | 6 (27%) | |
| C | 1 (5%) | |
| Unable To Be Determined | 3 (14%) | |
| CLIP Stage, n (%) | ||
| 0 | 0 (0%) | |
| 1 | 0 (0%) | |
| 2 | 5 (23%) | |
| 3 | 8 (36%) | |
| 4 | 3 (14%) | |
| 5 | 1 (5%) | |
| 6 | 0 (0%) | |
| Unable To Be Determined | 5 (23%) | |